As Cvs Health Corp (CVS) Stock Value Declined, Holder Washington Trust Company Has Trimmed Its Holding by $9.27 Million

May 23, 2018 - By Peter Erickson

CVS Health Corporation (NYSE:CVS) LogoInvestors sentiment decreased to 0.72 in 2017 Q4. Its down 0.16, from 0.88 in 2017Q3. It dived, as 115 investors sold CVS shares while 600 reduced holdings. 134 funds opened positions while 380 raised stakes. 815.59 million shares or 1.76% more from 801.45 million shares in 2017Q3 were reported. 159,815 are owned by Jupiter Asset Limited. Hills Financial Bank And Tru Com holds 44,182 shares or 0.94% of its portfolio. Convergence Ltd Llc invested in 0.65% or 67,200 shares. Lucus Advsr Lc invested in 4,573 shares. Meiji Yasuda Life Insur owns 30,558 shares for 0.31% of their portfolio. Trustmark Commercial Bank Tru Department invested 0.04% in CVS Health Corporation (NYSE:CVS). Meridian Mgmt owns 20,815 shares. 19,500 were reported by Peloton Wealth Strategists. Spinnaker Tru has invested 0.14% of its portfolio in CVS Health Corporation (NYSE:CVS). Ingalls And Snyder Limited Liability Co owns 8,295 shares. Hutchinson Cap Management Ca accumulated 166,346 shares. Senator Investment Grp Lp owns 2.50 million shares for 1.94% of their portfolio. Wealthtrust Fairport Ltd Llc accumulated 5,651 shares. Boston Private Wealth Ltd Liability Com has 0.52% invested in CVS Health Corporation (NYSE:CVS). Weatherly Asset Lp stated it has 0.57% in CVS Health Corporation (NYSE:CVS).

Since February 16, 2018, it had 2 insider buys, and 1 insider sale for $713,454 activity. The insider DORMAN DAVID W bought $1.51M. BROWN C DAVID II bought $619,900 worth of stock.

Washington Trust Company decreased its stake in Cvs Health Corp (CVS) by 37.33% based on its latest 2017Q4 regulatory filing with the SEC. Washington Trust Company sold 128,688 shares as the company’s stock declined 17.45% with the market. The institutional investor held 216,023 shares of the medical and nursing services company at the end of 2017Q4, valued at $15.66 million, down from 344,711 at the end of the previous reported quarter. Washington Trust Company who had been investing in Cvs Health Corp for a number of months, seems to be less bullish one the $66.71 billion market cap company. The stock increased 0.18% or $0.12 during the last trading session, reaching $65.62. About 4.18M shares traded. CVS Health Corporation (NYSE:CVS) has declined 22.81% since May 23, 2017 and is downtrending. It has underperformed by 34.36% the S&P500.

Washington Trust Company, which manages about $1.78 billion US Long portfolio, upped its stake in Dowdupont Inc by 208,482 shares to 212,207 shares, valued at $15.11 million in 2017Q4, according to the filing. It also increased its holding in Starbucks Corp (NASDAQ:SBUX) by 109,968 shares in the quarter, for a total of 193,307 shares, and has risen its stake in Ishares Tr (IWM).

Analysts await CVS Health Corporation (NYSE:CVS) to report earnings on August, 14. They expect $1.61 earnings per share, up 21.05 % or $0.28 from last year’s $1.33 per share. CVS’s profit will be $1.64B for 10.19 P/E if the $1.61 EPS becomes a reality. After $1.48 actual earnings per share reported by CVS Health Corporation for the previous quarter, Wall Street now forecasts 8.78 % EPS growth.

More notable recent CVS Health Corporation (NYSE:CVS) news were published by: 247Wallst.com which released: “Alibaba, CVS, Tesla and Other Earnings to Watch For This Week” on April 29, 2018, also Seekingalpha.com with their article: “We Are Playing The CVS Hand” published on May 11, 2018, Seekingalpha.com published: “CVS: Going Long, And Understanding The Aetna Deal” on April 30, 2018. More interesting news about CVS Health Corporation (NYSE:CVS) were released by: Fool.com and their article: “5 Things You’ll Want to Know About CVS Health’s Plans for 2018 and Beyond” published on May 04, 2018 as well as Seekingalpha.com‘s news article titled: “CVS Health: A Store-Level Look At The Proposed Healthcare Giant” with publication date: April 26, 2018.

CVS Health Corporation (NYSE:CVS) Ratings Coverage

Among 13 analysts covering CVS Health (NYSE:CVS), 11 have Buy rating, 0 Sell and 2 Hold. Therefore 85% are positive. CVS Health had 24 analyst reports since December 4, 2017 according to SRatingsIntel. SunTrust maintained the stock with “Buy” rating in Tuesday, April 17 report. The rating was maintained by Leerink Swann on Friday, February 9 with “Outperform”. Robert W. Baird maintained the shares of CVS in report on Thursday, January 4 with “Hold” rating. Leerink Swann maintained it with “Buy” rating and $8500 target in Tuesday, April 10 report. Needham maintained the shares of CVS in report on Tuesday, January 2 with “Buy” rating. The rating was maintained by RBC Capital Markets on Thursday, February 8 with “Buy”. The company was maintained on Wednesday, January 17 by Robert W. Baird. The firm earned “Buy” rating on Wednesday, April 11 by Bank of America. The stock of CVS Health Corporation (NYSE:CVS) has “Buy” rating given on Wednesday, January 24 by Mizuho. Oppenheimer maintained it with “Buy” rating and $8600 target in Wednesday, May 2 report.

CVS Health Corporation (NYSE:CVS) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.